Exploring the neurobiological mechanisms of ketamine, psychedelics, and other rapid antidepressants
The recent development of novel, fast acting, and durable antidepressant treatments such as Ketamine, Brexanolone, and Psilocybin has disrupted our view of the neuroscience and treatment of mood disorders. Our focus is research into the basic and translational science of how these drugs work.
Anyone interested is welcome to participate!
When: Last Monday of the month, 4:00p
Where: Fort Neuroscience Research Building 9101 (9th floor, NRB; Medical Campus) and Zoom
Organizers: Oliver Krentzman and Aidan Evans-Strong (Graduate students, Neuroscience Program)
Individual events are listed on the ONR Calendar.
2025 Schedule
For inquiries contact Oliver Krentzman or Aidan Evans-Strong.
January 27, 2025
Aidan Evans-Strong (Al-Hasani lab, University of Health Sciences & Pharmacy/WashU Anesthesiology)
“MDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus” Science Advances, 2024
February 24, 2025
Lorenzo Pasquini (University of California, San Francisco)
“Neural and Physiological Correlates of Psychedelic Sub-states”
March 31, 2025
Jake Roeglin (Pignatelli lab, WashU Psychiatry)
“Targeting NMDAR metaplasticity in psychiatric disorders: Lessons from Rapastinel”
April 28, 2025
David Bender (WashU Psychiatry)
“Psychological support processes in psychedelic treatments”
June 30, 2025
Tyler Ekins (University of Michigan)
“Psychedelic control of prefrontal pyramidal neurons”
September 30, 2024
Ginger Nicol (WashU Psychiatry)
“Clinical studies and the new center; Discussion on translational research training opportunities”
October 28, 2024
Candace Lewis (Arizona State University)
“Moments Shaping Your Epigenome: Exploring Experiences that Regulate Brain and Behavior”
November 25, 2024
Leor Roseman (University of Exeter)
“Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy; Discussion on paradigmatic tensions between biological psychiatry and psychedelic research”